WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medi...(surgery has led him to achieve medical ...),Health

Date:6/4/2009

surgery has led him to achieve medical "firsts" in New Jersey regarding transplant surgery, including performing a transplant on the youngest pediatric patient in the state, performing New Jersey's first laparoscopic kidney donation surgery, and performing the state's first isolated pancreas transplant. He operates at both Saint Barnabas Medical Center and Newark Beth Israel Medical Center.

Dr. Geffner received his medical degree from the University of Medicine and Dentistry of New Jersey, New Jersey Medical School and completed a fellowship in transplant surgery at the University of Wisconsin Medical School. A talented surgeon, he is a published author and has made several presentations at national surgical conferences.

Dr. Geffner plays an active role in the community and is involved with "Live from Kidney Transplant," a series of live video telecasts of transplant surgery to high school students by Liberty Science Center. He is the Region 2 Representative on the Pancreas Transplantation Committee for the United Network for Organ Sharing.

He was also the Medical Director of the New Jersey Organ and Tissue Sharing Network. In 2005, he received the National Medical Award for Excellence in Transplantation by the Kidney and Urology Foundation of America, Inc.

Saint Barnabas Health Care System Renal and Pancreas Transplant Division

The Saint Barnabas Renal and Pancreas Transplant Division, with programs at Saint Barnabas Medical Center in Livingston, N.J. and Newark Beth Israel Medical Center, is one of the top ten largest kidney transplant programs in the nations with more than 270 cases per year.

'/>"/>

SOURCE Saint Barnabas Medical Center Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
2. Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
3. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
4. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
5. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
6. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
7. First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
8. Creighton Medical Laboratories First to Offer New Cancer Test
9. Spherix Reports First Quarter 2009 Earnings
10. Tris Pharma Announces Acceptance of Its First Two NDAs
11. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus